Along with TB medication, ↑ prevention, immunity & ↓ risk factors to #endTB | Dr Randeep Guleria | #endTB Dialogues

This Podcast features a conversation with Dr Randeep Guleria, Director of All India Institute of Medical Sciences (AIIMS), Delhi, and Chairman of Indian government's Technical Working Group on Latent #Tuberculosis Infection (LTBI). He is among the LEADERS featured in #EndTB Dialogues - a special CNS series, presenting insightful and thought-provoking interviews with leaders to accelerate progress towards ending TB.

Launched in early October 2019, this #endTBdialogues series underpins the URGENCY to step up the fight against the epidemic.
#EndTBdialogues feature conversations with those who have spent years in fighting the world's top infectious killer disease. Business as usual will fail us in meeting the #endTB target by 2030. New/fresh thinking is vital to reimagine every critical cog-in-the-wheel to end TB, as well as accelerate progress towards other SDGs.
He was in conversation with CNS Managing Editor Shobha Shukla. Shobha is also the Coordinator of APCAT Media (Asia Pacific regional media network to end TB and #tobacco, and #beatNCDs).

For more information be welcome to visit:


team CNS